PD153035 hydrochloride (ZM 252868) is a effective and selective inhibitor of EGFR (Ki: 5.2 pM, IC50: 29 pM); few influence against FGFR, PGDFR, InsR, CSF-1, and Src.
More Information Supplier Page
Carboplatin is an organoplatinum compound that possesses antineoplastic activity.
More Information Supplier Page
Carboplatin is an organoplatinum compound that possesses antineoplastic activity.
More Information Supplier Page 
KYA1797K is a highly potent and selective inhibitor. Wnt/β-catenin IC50 is 0.75 μM through TOPflash assay.
More Information Supplier Page
KYA1797K is a highly potent and selective inhibitor. Wnt/β-catenin IC50 is 0.75 μM through TOPflash assay.
More Information Supplier Page
KYA1797K is a highly potent and selective inhibitor. Wnt/β-catenin IC50 is 0.75 μM through TOPflash assay.
More Information Supplier Page KYA1797K is a highly potent and selective inhibitor. Wnt/β-catenin IC50 is 0.75 μM through TOPflash assay.
More Information Supplier Page 
I-BRD9 is the first selective cellular inhibitor for BRD9 with pIC50 of 7.3.
More Information Supplier Page
I-BRD9 is the first selective cellular inhibitor for BRD9 with pIC50 of 7.3.
More Information Supplier Page
I-BRD9 is the first selective cellular inhibitor for BRD9 with pIC50 of 7.3.
More Information Supplier Page 
